Showing 1 - 20 results of 173,592 for search '(( 5 a decrease ) OR ((( 10 ((mg decrease) OR (_ decrease)) ) OR ( 5 non decrease ))))', query time: 1.41s Refine Results
  1. 1

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  12. 12

    Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial by Seyyed Abbas Zojaji (5208589)

    Published 2022
    “…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”
  13. 13
  14. 14

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…<b>(D)</b> The number of recent transposon insertions [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010345#pgen.1010345.ref022" target="_blank">22</a>] as a function of <i>NRPE1’</i> genotype and the number of mCHG-decreasing alleles. …”
  15. 15
  16. 16
  17. 17

    Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

    Published 2025
    “…The red line represents the significance threshold (<i>P < </i>5 × 10<sup>−8</sup>). Green dots indicate SNPs that have been previously shown in GWAS to be associated with knee OA or OA in general [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0325819#pone.0325819.ref007" target="_blank">7</a>,<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0325819#pone.0325819.ref009" target="_blank">9</a>]. …”
  18. 18
  19. 19
  20. 20